Imaging services provider Medical Resources of Hackensack, NJ, was delisted last month from the NASDAQ stock exchange. Medical Resources’ common stock was delisted on April 22 when NASDAQ advised the company that it does not conform to the
Imaging services provider Medical Resources of Hackensack, NJ, was delisted last month from the NASDAQ stock exchange. Medical Resources common stock was delisted on April 22 when NASDAQ advised the company that it does not conform to the requirements for listing on either the NASDAQ National Market or the NASDAQ SmallCap Market. The company believes its stock may be eligible for trading on NASDAQs OTC Bulletin Board. Medical Resources has the right to appeal NASDAQs decision.
The news paints a bleak picture of the status of Medical Resources business. In March, the company hired investment banking firm BT Alex. Brown of New York City and announced that it would seek an acquisition partner (SCAN 3/31/99). It also reported mediocre results for 1998 (end-December), posting a net loss of $19.9 million. The company attributed the loss to charges related to doubtful accounts receivable and charges associated with the settlement of a class-action lawsuit.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.